Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05479461 · ClinicalTrials.gov registry record · NA

Technology-enabled Management Versus Usual Care for Blood Pressure

A NA study of Hypertension, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
3
Study locations

NCT05479461: Recruiting NA study of Hypertension, sponsored by Stanford University.

NCT05479461 is a NA study of Hypertension that is actively recruiting participants, run by Stanford University. The registered enrollment target is 200 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05479461, a NA study of Hypertension, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
3
Study locations

Study Summary

Two arm parallel randomized clinical trial

Conditions Studied

Interventions

  • OTHER Usual Care
  • OTHER Digital Hypertension Management System

Study Locations (3)

Georgia

  • Morehouse School of Medicine - Atlanta
  • Lake Country Medical Group - Eatonton

California

  • Stanford Health Care - Palo Alto

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-06-13
Est. Completion 2025-09-15
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT05479461

The ClinicalTrials.gov registry entry for NCT05479461 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT05479461 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Georgia, California.

Frequently Asked Questions

What is clinical trial NCT05479461 about?

NCT05479461 is a clinical study titled "Technology-enabled Management Versus Usual Care for Blood Pressure". Two arm parallel randomized clinical trial

What is the current status of trial NCT05479461?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-06-13. Estimated completion is 2025-09-15.

What conditions does trial NCT05479461 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT05479461?

The interventions under investigation include: Usual Care (OTHER), Digital Hypertension Management System (OTHER).

Who is sponsoring clinical trial NCT05479461?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05479461 being conducted?

This trial has 3 study locations across California, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.